Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Gerresheimer (0NTI) Share Price & Analysis

4 Followers

0NTI Stock Chart & Stats

€32.20€0.00(0.00%)
At close: 4:30 PM GMT
€25€27.5€30€32.5Aug 10Aug 24Sep 7Sep 21Oct 5Oct 19Nov 2
Day’s Range
EUR 31.48 - EUR 32.20
52-Week Range
EUR 14.98 - EUR 34.04
Previous Close
EUR 32.20
Volume
N/A
Average Volume (3M)
47.86K
Market Cap
EUR 1.11B
Enterprise Value
EUR 3.53B
Total Cash (Recent Filing)
EUR 167.61M
Total Debt (Recent Filing)
EUR 2.21B
Price to Earnings (P/E)
―
Beta
0.60
Next Earnings
Feb 25, 2027 (Est.)
EPS Estimate
0.58
Next Dividend Ex-Date
N/A
Dividend Yield
0.12%

Bulls Say, Bears Say

Bulls Say

Steady Revenue Growth

Revenue growth across several years indicates expanding demand for Gerresheimer’s pharmaceutical packaging and delivery products. Continued top-line expansion provides a durable base for operating leverage and supports investment in specialized products, customer programs, and future capacity.

Positive Operating Cash Flow

Positive operating cash flow demonstrates that the core business continues to convert customer sales into cash despite recent profitability challenges. This underlying cash generation supports ongoing operations and provides some internal funding capacity for investment and debt servicing.

Recurring Healthcare Demand

Products used to store, protect, and administer medicines are tied to continuing pharmaceutical production rather than purely discretionary purchases. Long-term customer relationships and recurring volume demand can support business resilience and make specialized solutions harder to replace.

Bears Say

Swing To Net Loss

The shift from consistent operating profitability in 2020–2024 to substantial EBIT and net losses in 2025 is a material deterioration in earnings quality. If not reversed, weaker profitability could reduce reinvestment capacity and undermine returns from the company’s growing revenue base.

Higher Leverage

Rising debt alongside a shrinking equity base increases financial risk and reduces flexibility during an operating downturn. Greater leverage can constrain capital allocation, raise dependence on financing, and make it harder for Gerresheimer to absorb further earnings weakness.

Deeply Negative Free Cash Flow

Large negative free cash flow means positive operating cash generation is not covering investment, working-capital needs, or other cash uses. Persistent cash conversion weakness increases reliance on external financing, which is especially concerning while debt is rising and earnings are negative.

Gerresheimer News

0NTI FAQ

What was Gerresheimer’s price range in the past 12 months?
Gerresheimer lowest share price was €14.98 and its highest was €34.04 in the past 12 months.
What is Gerresheimer’s market cap?
Gerresheimer’s market cap is €1.11B.
When is Gerresheimer’s upcoming earnings report date?
Gerresheimer’s next earnings report is estimated for Feb 25, 2027 (not yet confirmed), which is in 112 days.
How were Gerresheimer’s earnings last quarter?
Gerresheimer released its earnings results on Oct 30, 2026. The company reported €0.61 earnings per share for the quarter, beating the consensus estimate of €0.273 by €0.337.
Is Gerresheimer overvalued?
According to Wall Street analysts Gerresheimer’s price is currently Overvalued.
Does Gerresheimer pay dividends?
Gerresheimer does not currently pay dividends.
What is Gerresheimer’s EPS estimate?
Gerresheimer’s EPS estimate is 0.58.
How many shares outstanding does Gerresheimer have?
Gerresheimer has 34,540,000 shares outstanding.
What happened to Gerresheimer’s price movement after its last earnings report?
Gerresheimer reported an EPS of €0.61 in its last earnings report, beating expectations of €0.273. Following the earnings report the stock price went up 0.609%.
Which hedge fund is a major shareholder of Gerresheimer?
Currently, no hedge funds are holding shares in GB:0NTI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology